Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith A Perez

Showing results (71-80 of 324) with videos related to

Pageof 33
Sort By:
Breast Disease|November 2, 2016
Breast cancer brain metastases: Molecular subtype, treatment and survivalJennifer A Crozier, Lauren F Cornell, Bhupendra Rawal, et al.
Plos One|May 29, 2015
Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer RegistriesWenjie Zhu, Edith A Perez, Ruoxi Hong, et al.
Trends in Molecular Medicine|March 8, 2011
MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancerCathy A Andorfer, Brian M Necela, E Aubrey Thompson, et al.
Breast Cancer Research and Treatment|January 23, 2010
Adjuvant therapy of triple negative breast cancerEdith A Perez, Alvaro Moreno-Aspitia, E Aubrey Thompson, et al.
Cancer Treatment Reviews|October 2, 2013
HER2 testing: current status and future directionsEdith A Perez, Javier Cortés, Ana Maria Gonzalez-Angulo, et al.
Seminars in Oncology|October 19, 2004
Future options with trastuzumab for primary systemic and adjuvant therapyJosé Baselga, Luca Gianni, Charles Geyer, et al.
Mayo Clinic Proceedings|March 14, 2007
The role of mammography in male patients with breast symptomsStephanie L Hines, Winston W Tan, Mona Yasrebi, et al.
Cancer|June 27, 2007
Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancerLouis P Garrison, Deborah Lubeck, Deepa Lalla, et al.
Breast Cancer Research and Treatment|June 27, 2002
Weekly paclitaxel in women age 65 and above with metastatic breast cancerEdith A Perez, Charles L Vogel, David H Irwin, et al.
Cancer|August 19, 2007
Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeksJanice L Gabrilove, Edith A Perez, Dianne K Tomita, et al.
Pageof 33

Showing results (71-80 of 324) with videos related to

Sort By:
Pageof 33
Breast Disease|November 2, 2016
Breast cancer brain metastases: Molecular subtype, treatment and survivalJennifer A Crozier, Lauren F Cornell, Bhupendra Rawal, et al.
Plos One|May 29, 2015
Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer RegistriesWenjie Zhu, Edith A Perez, Ruoxi Hong, et al.
Trends in Molecular Medicine|March 8, 2011
MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancerCathy A Andorfer, Brian M Necela, E Aubrey Thompson, et al.
Breast Cancer Research and Treatment|January 23, 2010
Adjuvant therapy of triple negative breast cancerEdith A Perez, Alvaro Moreno-Aspitia, E Aubrey Thompson, et al.
Cancer Treatment Reviews|October 2, 2013
HER2 testing: current status and future directionsEdith A Perez, Javier Cortés, Ana Maria Gonzalez-Angulo, et al.
Seminars in Oncology|October 19, 2004
Future options with trastuzumab for primary systemic and adjuvant therapyJosé Baselga, Luca Gianni, Charles Geyer, et al.
Mayo Clinic Proceedings|March 14, 2007
The role of mammography in male patients with breast symptomsStephanie L Hines, Winston W Tan, Mona Yasrebi, et al.
Cancer|June 27, 2007
Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancerLouis P Garrison, Deborah Lubeck, Deepa Lalla, et al.
Breast Cancer Research and Treatment|June 27, 2002
Weekly paclitaxel in women age 65 and above with metastatic breast cancerEdith A Perez, Charles L Vogel, David H Irwin, et al.
Cancer|August 19, 2007
Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeksJanice L Gabrilove, Edith A Perez, Dianne K Tomita, et al.
Pageof 33